| Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology WJ Koh, NR Abu-Rustum, S Bean, K Bradley, SM Campos, KR Cho, ... Journal of the National Comprehensive Cancer Network 17 (1), 64-84, 2019 | 976 | 2019 |
| Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology WJ Koh, NR Abu-Rustum, S Bean, K Bradley, SM Campos, KR Cho, ... Journal of the National Comprehensive Cancer Network 16 (2), 170-199, 2018 | 680 | 2018 |
| NCCN guidelines insights: cervical cancer, version 1.2020: featured updates to the NCCN guidelines NR Abu-Rustum, CM Yashar, S Bean, K Bradley, SM Campos, HS Chon, ... Journal of the National Comprehensive Cancer Network 18 (6), 660-666, 2020 | 310 | 2020 |
| Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology N Abu-Rustum, C Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (2), 181-209, 2023 | 252 | 2023 |
| Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology WJ Koh, BE Greer, NR Abu-Rustum, SM Campos, KR Cho, HS Chon, ... Journal of the National Comprehensive Cancer Network 15 (1), 92-120, 2017 | 197 | 2017 |
| NCCN Guidelines® insights: uterine neoplasms, version 3.2021: featured updates to the NCCN guidelines NR Abu-Rustum, CM Yashar, K Bradley, SM Campos, J Chino, HS Chon, ... Journal of the National Comprehensive Cancer Network 19 (8), 888-895, 2021 | 141 | 2021 |
| Gestational trophoblastic neoplasia, version 2.2019, NCCN clinical practice guidelines in oncology NR Abu-Rustum, CM Yashar, S Bean, K Bradley, SM Campos, HS Chon, ... Journal of the National Comprehensive Cancer Network 17 (11), 1374-1391, 2019 | 140 | 2019 |
| BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival DC Marchion, HM Cottrill, Y Xiong, N Chen, E Bicaku, WJ Fulp, N Bansal, ... Clinical Cancer Research 17 (19), 6356-6366, 2011 | 116 | 2011 |
| Durvalumab plus carboplatin/paclitaxel followed by maintenance durvalumab with or without olaparib as first-line treatment for advanced endometrial cancer: the phase III DUO-E … SN Westin, K Moore, HS Chon, JY Lee, J Thomes Pepin, M Sundborg, ... Journal of Clinical Oncology 42 (3), 283-299, 2024 | 102 | 2024 |
| A phase III study of pafolacianine injection (OTL38) for intraoperative imaging of folate receptor–positive ovarian cancer (Study 006) JL Tanyi, LM Randall, SK Chambers, KA Butler, IS Winer, CL Langstraat, ... Journal of Clinical Oncology 41 (2), 276-284, 2023 | 93 | 2023 |
| NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024: Featured Updates to the NCCN Guidelines NR Abu-Rustum, CM Yashar, R Arend, E Barber, K Bradley, R Brooks, ... Journal of the National Comprehensive Cancer Network 21 (12), 1224-1233, 2023 | 83 | 2023 |
| Targeted therapies in gynecologic cancers HS Chon, W Hu, JJ Kavanagh Current cancer drug targets 6 (4), 333-363, 2006 | 61 | 2006 |
| Microarray-based gene expression studies in ovarian cancer HS Chon, JM Lancaster Cancer Control 18 (1), 8-15, 2011 | 57 | 2011 |
| Randomized phase II trial of triapine-cisplatin-radiotherapy for locally advanced stage uterine cervix or vaginal cancers CA Kunos, SJ Andrews, KN Moore, HS Chon, SP Ivy Frontiers in oncology 9, 1067, 2019 | 54 | 2019 |
| The role of surgery in the management of epithelial ovarian cancer I Ramirez, HS Chon, SM Apte Cancer Control 18 (1), 22-30, 2011 | 49 | 2011 |
| Analysis of chemotherapeutic response in ovarian cancers using publicly available high-throughput data JG Bosquet, DC Marchion, HS Chon, JM Lancaster, S Chanock Cancer research 74 (14), 3902-3912, 2014 | 46 | 2014 |
| In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival E Bicaku, Y Xiong, DC Marchion, HS Chon, XB Stickles, N Chen, ... British journal of cancer 106 (12), 1967-1975, 2012 | 41 | 2012 |
| Using the radiosensitivity index (RSI) to predict pelvic failure in endometrial cancer treated with adjuvant radiation therapy H Mohammadi, A Prince, NB Figura, JS Peacock, DC Fernandez, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 496-502, 2020 | 40 | 2020 |
| Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity PL Judson, E Al Sawah, DC Marchion, Y Xiong, E Bicaku, NB Zgheib, ... International Journal of Gynecologic Cancer 22 (6), 2012 | 38 | 2012 |
| A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer HW Bulls, AI Hoogland, B Kennedy, BW James, BL Arboleda, S Apte, ... Gynecologic oncology 152 (2), 310-315, 2019 | 37 | 2019 |
